Golden
Create custom queries with the Golden Research Engine

List of therapeutics companies

223 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.

Caribou Biosciences is a Berkeley California based private company founded in 2011 by Jennifer Doudna and Rachel Haurwitz based on CRISPR technology.

A company developing biotherapeutics for the delivery of large drug molecules, peptides, proteins and antibodies

Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.

Intellia Therapeutics is a biotechnology company founded in 2014, based in Cambridge, MA that develops biopharmaceuticals using CRISPR-Cas9 gene editing technology.

Illumina Accelerator is Illumina's accelerator arm focusing on investing in genomic startup companies.

Orbit Discovery offers a DNA-encoded peptide display technology to identify potential peptide drugs for a range of chronic diseases.

A biotechnology company researching and developing therapies to increase human lifespan.

A synthetic biology company that designs, builds and tests genetic circuits for the purposes programming cell therapies. Their first therapeutic candidates are aimed at solid tumors and blood cancer and the company plans to move beyond oncology.

A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018.

A company that develops and commercializes products for the treatment of dermatological diseases

A biopharmaceutical company focused on the research and development of antibiotics to treat serious infections

Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited.

A biopharmaceutical and gene editing company founded in 2013. CRISPR Therapeutics AG is based in Zug, Switzerland and CRISPR Therapeutics, Inc. is the U.S. subsidiary with R&D operations in Cambridge, Massachusetts and business offices in London, U.K.

A biotechnology company founded in 2015 which operates as a subsidiary of Gilead Sciences and Kite Pharma. The company developed a platform for custom cell engineering called synNotch to be used for anticancer therapies. Their system can also be used to develop cell-based therapies for autoimmune and degenerative disorders.

A company developing Hypoxia Inducible Factor therapies to treat kidney diseases and other conditions

Human genome sequencing company founded in 2013 and based in San Diego, CA. Human Longevity Inc. is building a database with genomic and phenotypic information and aims to make medicine more data-driven by combining DNA sequencing, expert analysis and machine learning

A biopharmaceutical company focused on discovery and development of small-molecule drugs to treat genetic and rare diseases

A company that deveops therapeutics for depression, CNS and ophthalmological disorders

Medicago is a biopharmaceutical company founded in 1999, based in Quebec, Quebec, Canada, that uses plant-based manufacturing to develop vaccines and protein-based therapeutics. In 2013 became a subsidiary of Mitsubishi Tanabe Pharma Corporation.

Emerald Therapeutics is a biotechnology company located in San Fransisco, California, founded by Brian Frezza and DJ Klienbaum in 2010. Emerald Therapeutics offers cloud a based software and hardware platform that allows researchers to remotely perform automated scientific laboratory experiments.

A biotechnology and data science company based in Salt Lake City, Utah, founded in 2013, that combines biology with artificial intelligence for drug discovery. Using human cell models of diseases, Recursion captures microscopic images to build biological datasets and computational techniques identify disease-associated biological changes.

miRagen is a clinical stage biopharmaceutical company developing innovative microRNA-targeting therapies to improve human health.

An exosome therapeutics company founded in 2016 and based in Oxford, UK, that uses exosomes to deliver small and large molecule therapeutics. The company has a proprietary technology to modify exosomes to target specific organs such as the brain and central nervous system.

AOBiome Therapeutics is a therapeutics company, based in Newton, Massachusetts and founded in 2013, that conducts clinal-stage research to address inflammatory conditions with Ammonia Oxidizing Bacteria (AOB).

A biopharmaceutical company that develops nanotherapeutic treatments for ocular diseases and other eye related conditions

A biotechnology company developing drugs and treatments to diminish negative health effects associated with aging.

A biopharmaceutical company that develops treatments for multi-drug resistant (MDR) bacterial infection

Agile Therapeutics is a biotechnology and pharmaceutical company headquartered in Princeton, New Jersey developing contraceptive and healthcare products for women.

Voyager Therapeutics is a biotechnology company founded in 2014 that is headquartered in Cambridge, Massachusetts developing gene therapies to treat neurological disorders.

Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.

A therapeutics company founded in 2016 working in drug discovery and development using fungi. LifeMine uses genomics approaches to search for biosynthetic genes in eukaryotic microbes for the discovery of naturally inspired drugs to treat previously untreatable and significant chronic diseases.

Rheostat, located at 300 Technology Square, in Cambridge, Massachusetts is a biotech company developing treatments for neurodegenerative diseases by targeting mitophagy and autophagy pathways.

Develops medicines for patients suffering from Alzheimer's disease and other neurological disorders.

Biotherapeautics company founded in 2014 and based in Paris that uses proprietary methods in synthetic biology, protein and genome engineering to produce Eligobiotics, products which intervene with the microbiome as diagnostics, antimicrobials and modulators of host-microbiome interactions.

A Biopharmaceutical company based in Los Angeles and founded in 2007 that develops therapeutics and technologies using nanotechnology for cancer and other critical illnesses.

Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.

Aegle Therapeutics Corporation, a regenerative medicine company isolating extracellular vesicles ("EVs") from allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat severe dermatological conditions, including burns and epidermolysis bullosa (“EB”).

Cognition Therapeutics is a biotechnology and pharmaceutical company developing therapeutics for Alzheimer’s disease and other neurodegenerative disorders that is headquartered in Pittsburgh, Pennsylvania in 2007 by Gilbert Rishton and Susan Catalano.

Biotechnology company founded in 2015 that develops and commercializes synthetic lipid compounds and cancer immunotherapy agents. iOx Therapeutics is an OSI spinout.

YourChoice Therapeutics is a biotechnology company founded in 2018 is developing contraceptives for men and women. The technology for their non-hormonal contraceptive products arose from research at the University of California, Berkeley.

CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia being to deliver bioactive molecules to treat diseases associated with the human gut microbiome.

A biotechnology company founded in 2013 that develops technology to treat heart disease using pluripotent stem cells. Disease in a dish and clinical trial in a dish platforms are used to develop cardiovascular drugs and perform cardio-toxicity safety testing for non-cardiovascular drugs.

A biotechnology company that develops Probodies, proteolytically-activated antibodies to treat cancer.

A biotechnology company founded in 2018 and based at University of California, Los Angeles (UCLA) that develops drug delivery systems for treating cancer.

OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.

A biotechnology company, founded in 2017 and based in San Francisco, with a platform that enables viruses to be engineered for use as therapeutics against antibiotic-resistant bacteria.

Oraya Therapeutics is a biotechnology company developing non-invasive therapies for eye diseases that is headquartered in San Francisco, California and was founded in 2007 by Michael Gertner.

A biotechnology company applying AI and genomics to precision medicine to address patient subpopulations that have unmet needs. Their pipeline of drug candidates address cancer, neurology, inflammation, infectious disease and metabolic disease. It is located in Palo Alto, California and was founded in 2014.

Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases.

Cynapsus Therapeutics is a pharmaceutical subsidiary of Sunovion developing a non-injectable rescue therapy for Parkinson’s disease symptoms. The company was founded in 2004 and is headquartered in Toronto, Ontario, Canada.

Envisagenics is a biotechnology company founded by Maria Luisa Pineda and Martin Akerman in 2014 and headquartered in New York City, New York using artificial intelligence and RNA sequencing to develop therapeutics to treat genetic diseases.

Rodin Therapeutics is a biotechnology company developing treatments for Alzheimer's disease that is headquartered in Cambridge, Massachusetts and was founded in 2013 by Ankit Mahadevia and Martin Jefson.

Sage Therapeutics is a biopharmaceutical company founded by Douglas Covey and Steven Paul in 2010 and headquartered in Cambridge, Massachusetts focused on the discovery and development of medicines to address central nervous system disorders.

EpiBone is a biotechnology startup company developing bone reconstruction solutions using stem cells. Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig founded EpiBone in 2013 and the company is headquartered in New York City, New York.

Sarepta Therapeutics is a biopharmaceutical company founded by Marwan Fawaz in 1980 and headquartered in Cambridge, Massachusetts developing precision genetic medicines for the treatment of rare neuromuscular diseases.

Biopharmaceutical company focused on exploring effects of cytokine based therapies on cancer.

Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.

Anviro Therapeutics is a biotechnology company developing broad spectrum antiviral therapies.

Siolta Therapeutics develops microbiome analyses to test microbial-based therapeutics for the treatment and prevention of inflammatory diseases.

XEME Biopharma is a biotechnology company developing therapeutic cancer vaccines and cancer immunotherapy products.

A biotechnology company founded in 2006 and based in Baltimore, MD, that develops polymers to deliver DNA and RNA therapeutics.

SF17 Therapeutics is a company founded in 2018 and based in Berkeley, California, that uses analytics and AI to develop precision immune therapies to target autoimmune, auto-inflammatory disease and immune oncology conditions.

A Cambridge Massachusetts based biotechnology company founded in 2017 developing gene therapy platforms to target rare and unmet diseases.

Company combining artificial intelligence, biology and medicine to provide oncologists with services that help them treat patients. Products include assistance with molecular testing, clinical trials and treatment decisions.

ImStar Therapeutics is company developing treatments for ALS, dementia, and other neurodegenerative diseases.

A company developing therapies for psychological and neurological illnesses

Acorda is a biotechnology company founded in 1995 by Ron Cohen and headquartered in Ardsley, New York developing and commercializing neurology therapies for Parkinson's disease, migraines, and multiple sclerosis.

Precision therapeutics company developing epigenetic therapies that target arginine methylation in cancer.

Demonpore, founded in 2018 and based in the San Francisco Bay Area, is developing mechanical nanopore sensors to measure molecules relevant to human health.

Renew Biopharma is a synthetic biology company that develops therapeutics targeting pain management, neurodegenerative diseases, and traumatic brain injuries using cannabinoids.